Trevor Martin

Founder of Mammoth Biosciences

Co-Founder and CEO
2017 - Current
Building the CRISPR platform for the next generation of potentially curative therapies and beyond.

Graduate Student
2011 - 2017
Research concerning genetics and statistics in Fraser Lab at Stanford University

Undergraduate Researcher, Storey Lab
2008 - 2011
• Conducted independent research in quantitative biology • Main project involved developing and applying novel statistical methods to genomic data in order to understand environment specific regulation of gene expression, which has implications for drug design, personalized genomics, and is a little understood aspect of essential biology • Tested quantitative results through laboratory work including quantitative PCR and in vivo allele swaps

Total Funding: $22M